ShockWave Medical, Inc. (SWAV) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Santa Clara, CA, United States. Der aktuelle CEO ist Douglas E. Godshall.
SWAV hat IPO-Datum 2019-03-07, 1,468 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $12.57B.
ShockWave Medical, Inc. is a medical device company that develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases globally. The company's product portfolio includes M5 catheters for above-the-knee peripheral artery disease, C2 catheters for coronary artery disease, and S4 catheters for below-the-knee peripheral artery disease. ShockWave Medical serves interventional cardiologists, vascular surgeons, and interventional radiologists through a network of sales representatives, managers, and distributors. Founded in 2009 and headquartered in Santa Clara, California, the company addresses critical treatment needs across multiple vascular intervention markets.
